# Thrombolysis of Urokinase for Minor Stroke

Study · id `cardio:ct-nct04420351` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04420351](<https://clinicaltrials.gov/study/NCT04420351>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT04420351

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1005 participants.

## Technical summary

Registry record NCT04420351. Randomized; single masking; primary purpose treatment. Start 2020-10-04 (actual); primary completion 2023-02-18 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1005 participants (enrolled count; ClinicalTrials.gov record NCT04420351, source copy `cardio:ctgov-nct04420351-2023-11-14`, retrieved 2026-11-18)
- Started: 2020-10-04 (actual) (ClinicalTrials.gov record NCT04420351, source copy `cardio:ctgov-nct04420351-2023-11-14`, retrieved 2026-11-18)
- Primary completion: 2023-02-18 (actual) (ClinicalTrials.gov record NCT04420351, source copy `cardio:ctgov-nct04420351-2023-11-14`, retrieved 2026-11-18)
- Completion: 2023-02-18 (actual) (ClinicalTrials.gov record NCT04420351, source copy `cardio:ctgov-nct04420351-2023-11-14`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT04420351, source copy `cardio:ctgov-nct04420351-2023-11-14`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04420351-2023-11-14`, retrieved 2026-11-18)

## The registry's words

- Brief title: Thrombolysis of Urokinase for Minor Stroke
- Acronym: TRUST
- Condition: Minor Stroke
- Intervention (Drug): Urokinase thrombolysis
- Intervention (Drug): Aspirin;Clopidogrel
- Lead sponsor: The First Affiliated Hospital of Zhengzhou University
- Lead sponsor class: OTHER
- Collaborator: Beijing Tiantan Hospital
- Collaborator class: OTHER
- Collaborator: Shanghai 10th People's Hospital
- Collaborator class: OTHER
- Collaborator: General Hospital of Shenyang Military Region
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: The First Affiliated Hospital of Zhengzhou University (`cardio:org-the-first-affiliated-hospital-of-zhengzhou-university`)
- Registry lists this organization as a collaborator: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)
- Registry lists this organization as a collaborator: Shanghai 10th People's Hospital (`cardio:org-shanghai-10th-people-s-hospital`)
- Registry lists this organization as a collaborator: General Hospital of Shenyang Military Region (`cardio:org-general-hospital-of-shenyang-military-region`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of intravenous urokinase vs best medicine treatment on functional outcome for patients with acute minor stroke (TRUST): a randomized controlled trial (`cardio:pubmed-39757192`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy and safety of urokinase intravenous thrombolysis in minor stroke according to large vessel occlusion status: a subgroup analysis of the TRUST trial (`cardio:pubmed-43015686`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 38c5b389ba59598b3a6bf497e339f5fc79698bb11c5bbfd3764a57bca10dd0b3
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
